BioCentury
ARTICLE | Clinical News

Ovax: Phase I/II data

February 8, 2016 8:00 AM UTC

A double-blind, U.S. Phase I/II trial in 34 patients with relapsed stage III or IV ovarian cancer who have undergone debulking followed by intraperitoneal chemotherapy showed that once-weekly 0.5, 2.5...